These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 29858430)

  • 1. Hepatitis B virus reactivation in patients treated with immunosuppressive drugs: a practical guide for clinicians.
    Koffas A; Dolman GE; Kennedy PT
    Clin Med (Lond); 2018 Jun; 18(3):212-218. PubMed ID: 29858430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of Hepatitis B Reactivation in Patients Receiving Immunosuppressive Therapy: a Case Series and Appraisal of Society Guidelines.
    Etienne S; Vosbeck J; Bernsmeier C; Osthoff M
    J Gen Intern Med; 2023 Feb; 38(2):490-501. PubMed ID: 36138278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B Reactivation in Rheumatic Diseases: Screening and Prevention.
    Koutsianas C; Thomas K; Vassilopoulos D
    Rheum Dis Clin North Am; 2017 Feb; 43(1):133-149. PubMed ID: 27890170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Hepatitis B Reactivation Among Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors.
    Atteya A; Ahmad A; Daghstani D; Mushtaq K; Yassin MA
    Cancer Control; 2020; 27(1):1073274820976594. PubMed ID: 33297765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B Reactivation: A Review of Clinical Guidelines.
    Wang Y; Han SB
    J Clin Gastroenterol; 2021 May-Jun 01; 55(5):393-399. PubMed ID: 33828065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of psoriasis patients with hepatitis B or hepatitis C virus infection.
    Bonifati C; Lora V; Graceffa D; Nosotti L
    World J Gastroenterol; 2016 Jul; 22(28):6444-55. PubMed ID: 27605880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection.
    Salpini R; Battisti A; Colagrossi L; Di Carlo D; Fabeni L; Piermatteo L; Cerva C; Lichtner M; Mastroianni C; Marignani M; Maylin S; Delaugerre C; Morisco F; Coppola N; Marrone A; Angelico M; Sarmati L; Andreoni M; Perno CF; Ceccherini-Silberstein F; Svicher V
    J Viral Hepat; 2019 Jul; 26(7):846-855. PubMed ID: 30974483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression and HBV reactivation.
    Shouval D; Shibolet O
    Semin Liver Dis; 2013 May; 33(2):167-77. PubMed ID: 23749673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention.
    Sagnelli C; Pisaturo M; Calò F; Martini S; Sagnelli E; Coppola N
    World J Gastroenterol; 2019 Jul; 25(26):3299-3312. PubMed ID: 31341357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B reactivation: diagnosis and management.
    Huang SC; Yang HC; Kao JH
    Expert Rev Gastroenterol Hepatol; 2020 Jul; 14(7):565-578. PubMed ID: 32448008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBV Reactivation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Narrative Review.
    Gentile G; Antonelli G
    Viruses; 2019 Nov; 11(11):. PubMed ID: 31717647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reactivation of chronic hepatitis B].
    Šperl J
    Vnitr Lek; 2013 Jul; 59(7):591-6. PubMed ID: 23909265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B Virus Reactivation: What Is the Issue, and How Should It Be Managed?
    Ekpanyapong S; Reddy KR
    Clin Liver Dis; 2020 Aug; 24(3):317-333. PubMed ID: 32620274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short article: Safety of targeted prophylaxis strategy in patients with resolved hepatitis B virus infection receiving rituximab for immune-mediated diseases.
    Spinicci M; Emmi G; Dies L; Barilaro A; Vitiello G; Mencarini J; Cavallo A; Bartoloni A; Bartalesi F
    Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):756-760. PubMed ID: 29649073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of hepatitis B reactivation during anti-TNF therapy; evaluation of patients with past hepatitis B infection.
    Sayar S; Kürbüz K; Kahraman R; Öztürk O; Çalışkan Z; Doğanay HL; Özdil K
    Turk J Gastroenterol; 2020 Jul; 31(7):522-528. PubMed ID: 32897226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease.
    Chen FW; Coyle L; Jones BE; Pattullo V
    Liver Int; 2013 Sep; 33(8):1203-10. PubMed ID: 23522150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hepatitis B virus reactivation due to treatment of COVID-19.
    Yip TC; Gill M; Wong GL; Liu K
    Hepatol Int; 2022 Apr; 16(2):257-268. PubMed ID: 35235148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learned from chemotherapeutic and immunosuppressant induced Hepatitis B reactivation - a case series.
    Nida' Ul-Huda A; Haniza O
    Med J Malaysia; 2021 Sep; 76(5):719-724. PubMed ID: 34508381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Biologics Treatment.
    Chen MH; Chen MH; Liu CY; Tsai CY; Huang DF; Lin HY; Lee MH; Huang YH
    J Infect Dis; 2017 Feb; 215(4):566-573. PubMed ID: 28011918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematological Malignancies and HBV Reactivation Risk: Suggestions for Clinical Management.
    Zannella A; Marignani M; Begini P
    Viruses; 2019 Sep; 11(9):. PubMed ID: 31540124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.